Number of Clinical Trials 2010
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 →
Where does your country rank? Pick it to see its position.
Related Health statistics
More ↓Interactive Map
Complete Data Rankings
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #108
Saint Kitts and Nevis
- #107
Rwanda
- #106
Qatar
- #105
Panama
- #104
Nepal
- #103
Myanmar
- #102
Martinique
- #101
Luxembourg
- #100
Haiti
- #99
Ecuador
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Trinidad and Tobago
In 2010, Trinidad and Tobago ranked #107 globally with a total of 1 clinical trial. This number is significantly lower than many of its Caribbean neighbors, indicating limited participation in clinical research. Contributing factors include a smaller population and less robust healthcare infrastructure compared to countries that lead in clinical trials, which often have more extensive resources and research institutions.
Taiwan
In 2010, Taiwan ranked #16 globally with a total of 121 clinical trials. This figure is notably higher than the global average, reflecting Taiwan's robust healthcare system and commitment to medical research. Factors contributing to this strong performance include a well-established biotechnology sector and supportive government policies that encourage clinical research initiatives.
Ethiopia
Ethiopia ranked #62 globally with a total of 4 clinical trials in 2010. This figure is notably low compared to more developed nations, reflecting the challenges faced in the region. Key drivers for this limited number include a lack of funding for research initiatives and a healthcare system that is still developing, impacting the capacity to conduct extensive clinical research.
United States
The United States ranked #1 globally with a total of 4,164 clinical trials in 2010. This figure significantly surpasses that of other countries, reflecting the U.S.'s strong position in medical research compared to the global average. The high number of clinical trials can be attributed to the country's robust pharmaceutical industry, extensive funding for research and development, and a diverse patient population that facilitates various study demographics.
Dominican Republic
In 2010, the Dominican Republic ranked #58 globally with a total of 5 clinical trials. This number is relatively low compared to regional leaders like Brazil, which has a significantly higher volume of trials. The country's limited number of clinical trials can be attributed to factors such as a developing healthcare infrastructure and a smaller pool of research funding, which impacts the capacity for extensive clinical research activities.
India
In 2010, India ranked #19 globally with a total of 92 clinical trials. This figure is notable compared to the global average, reflecting India's growing role in the clinical research landscape. Contributing factors include a large and diverse patient population, which facilitates recruitment for trials, and increasing investment in healthcare infrastructure and biotechnology sectors.
Ghana
In 2010, Ghana ranked #71 globally with a total of 3 clinical trials. This figure is relatively low compared to regional leaders, indicating a developing clinical research environment. Contributing factors include limited funding for research initiatives and a nascent regulatory framework, which affect the country's ability to attract and conduct clinical trials effectively.
Sri Lanka
Sri Lanka ranked #80 globally with 2 clinical trials in 2010. This figure is significantly lower than many of its regional peers, reflecting limited research infrastructure compared to countries like India, which has a more robust clinical trial ecosystem. Factors contributing to this low number include a smaller healthcare research budget and a less developed pharmaceutical industry, which impacts the country's ability to attract and conduct clinical research.
Malaysia
In 2010, Malaysia ranked #52 globally with 10 clinical trials conducted. This figure is notably lower than many of its regional peers, reflecting a growing but still developing clinical research landscape. Contributing factors include Malaysia's strategic location in Southeast Asia, which offers diverse patient populations, and government initiatives aimed at enhancing the country's healthcare and research capabilities.
Pakistan
In 2010, Pakistan ranked #45 globally with a total of 12 clinical trials. This figure is relatively low compared to neighboring India, which had a significantly higher number of clinical trials during the same period. The limited number of clinical trials in Pakistan can be attributed to challenges such as insufficient investment in research infrastructure and regulatory hurdles that hinder the growth of clinical research in the country.
Analysis & Context
In 2010, the United States led the world in the Number of Clinical Trials with a total of 4164, while globally, the range spanned from a minimum of 1 to a maximum of 4164. The global average for clinical trials conducted was approximately 82.50, with a median value of 10.00, highlighting significant disparities in research activity across different countries.
Global Leaders in Clinical Trials
The dominance of the United States in clinical trials is a reflection of its robust pharmaceutical industry, extensive research infrastructure, and significant investment in medical innovation. With 4164 trials, the U.S. conducted nearly nine times more trials than the next leading country, Germany, which hosted 473 trials. This disparity underscores the U.S.'s unparalleled capacity for medical research and development.
Other notable contributors include Canada with 368 trials and France with 351. These countries benefit from strong healthcare systems and government policies that support clinical research. The presence of major pharmaceutical companies and academic institutions in these regions further propels their research output.
Factors Influencing Low Trial Numbers
At the opposite end, several countries recorded only 1 clinical trial each, such as Panama, Ecuador, and Haiti. The limited number of trials in these regions can be attributed to economic constraints, limited healthcare infrastructure, and lesser investment in research and development. Political instability and regulatory challenges also play a role in hindering clinical research activities in these countries.
In regions like Luxembourg and American Samoa, the small population size and limited healthcare needs can also explain the lower numbers, as there is less demand for extensive clinical research compared to larger, more populous nations.
Year-over-Year Trends and Changes
Analyzing year-over-year changes reveals interesting dynamics in the clinical trials landscape. The United States saw an increase of 133 trials, representing a modest growth of 3.3%. In contrast, Germany experienced a substantial increase of 100 trials, marking a 26.8% rise, which can be linked to enhanced funding and strategic partnerships in the European Union for medical research.
Conversely, Brazil witnessed a decrease of 27 trials, a 14.6% reduction. This decline may be attributed to economic fluctuations and shifting governmental priorities away from research funding. Similarly, the Czech Republic and Argentina experienced declines of 41.4% and 52.4% respectively, reflecting potential challenges in maintaining consistent research funding and infrastructure.
Implications for Medical Research and Innovation
The distribution of clinical trials globally highlights the critical role of economic strength, policy support, and infrastructure in fostering medical research. Countries like the United States and Germany illustrate how strategic investments and supportive environments can lead to substantial contributions to global health advancements.
For countries with fewer trials, the focus may need to shift towards building research capacity, improving regulatory frameworks, and fostering international collaborations. Such efforts could enhance their participation in global medical research, potentially leading to innovations that are more inclusive of diverse populations and healthcare needs.
Overall, the data from 2010 underscores the importance of clinical trials as a cornerstone of medical innovation, with the potential to transform healthcare outcomes worldwide.
Frequently Asked Questions About Number of Clinical Trials in 2010
Which country conducted the most clinical trials in 2010?
The United States conducted the most clinical trials in 2010, with a total of 4,164 trials.
What was the average number of clinical trials conducted by countries in 2010?
The average number of clinical trials conducted by countries in 2010 was 82.5.
Which country conducted the fewest clinical trials in 2010?
Panama conducted the fewest clinical trials in 2010, with only 1 trial.
What was the median number of clinical trials conducted per country in 2010?
The median number of clinical trials conducted per country in 2010 was 9.5.
How many countries conducted only 1 clinical trial in 2010?
Ten countries conducted only 1 clinical trial in 2010, including Panama, Ecuador, and Trinidad and Tobago.
Which countries were in the top 3 for the number of clinical trials conducted in 2010?
The top 3 countries for the number of clinical trials conducted in 2010 were the United States with 4,164 trials, Germany with 473 trials, and Canada with 368 trials.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2010. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2010
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
›Embed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.